Janover Inc. (NASDAQ:JNVR – Get Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 45,900 shares, a growth of 43.4% from the May 31st total of 32,000 shares. Based on an average daily volume of 31,800 shares, the short-interest ratio is currently 1.4 days. Currently, 1.0% of the company’s shares are sold short.
Janover Price Performance
JNVR traded up $0.05 during mid-day trading on Monday, hitting $0.82. The stock had a trading volume of 4,217 shares, compared to its average volume of 22,912. The stock’s fifty day simple moving average is $1.00 and its 200-day simple moving average is $1.13. The firm has a market capitalization of $9.07 million and a price-to-earnings ratio of -1.86. Janover has a 1-year low of $0.70 and a 1-year high of $5.50.
Janover (NASDAQ:JNVR – Get Free Report) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.41 million during the quarter. Janover had a negative net margin of 211.51% and a negative return on equity of 88.39%.
Institutional Investors Weigh In On Janover
Janover Company Profile
Janover Inc engages in the provision of commercial property financing solutions. It operates an online platform that connects commercial mortgage borrowers, including owners, operators, and developers of commercial real estate and small business borrowers, looking for capital to refinance, build, or purchase commercial properties, including apartment buildings with commercial property lenders, such as banks, credit unions, REITs, debt funds, multifamily lenders, and others looking to deploy capital into commercial mortgages.
Read More
- Five stocks we like better than Janover
- Why Invest in 5G? How to Invest in 5G Stocks
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Janover Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Janover and related companies with MarketBeat.com's FREE daily email newsletter.